Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by hcdtradingon Oct 27, 2016 5:48pm

209 Views

Post# 25395416

RE:Updated presentation

So why would a major pharm company pay them 90 upfront and a billion in royalities afew years later if they could just buy them out right now for 500 mil and we can all relax? Big pharma are smart so they should save a few bucks and just write Sirona a check this week. haha

Bullboard Posts

Critical raw materials pioneer drives Europe’s clean energy transition